Rani Therapeutics Inc.
RANI | NASDAQ
$0.79
$0 (+0.08%)
Sep 22, 2026, 12:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3 | -1.30 | -2.50 | -4.61 | -38.93 | -12.94 |
PEG Ratio | 0.05 | 0.06 | -0.64 | -0.02 | 0.77 | 0.35 |
PS Ratio | 54.68 | 37.95 | n/a | n/a | 117.55 | 446.16 |
PB Ratio | 2.70 | 19.58 | 6.58 | 3.81 | 6.74 | -1.82 |
P/FCF Ratio | -4.75 | -1.09 | -1.61 | -2.92 | -9.75 | -12.76 |
P/OCF Ratio | -4.77 | -1.10 | -1.65 | -3.02 | -9.90 | -13.78 |
OCF/S Ratio | -1.15K | -3.45K | n/a | n/a | -1.19K | -3.24K |
Debt / Equity Ratio | 0.13 | 14.91 | 2.34 | 0.82 | n/a | -0.03 |
Quick Ratio | 4.21 | 1.50 | 6.36 | 20.96 | 45.30 | 14.12 |
Current Ratio | 4.21 | 1.50 | 6.36 | 20.96 | 45.30 | 14.12 |
Asset Turnover | 0.03 | 0.03 | n/a | n/a | 0.02 | 0.01 |
Interest Coverage | -13.25 | -10.59 | -13 | -59.24 | -110.73 | -133.42 |
Return on Equity | -89.89% | -1.51K% | -264.03% | -83% | -17.57% | 14.74% |
Return on Assets | -50.62% | -81.94% | -58.65% | -28.32% | -6.71% | -21.03% |
Return on Invested Capital | -80.59% | -160.57% | -119.01% | -60.88% | -42.44% | -21.92% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 44.89% | 100% | n/a | n/a | 100% | 100% |
Net Profit Margin | -1.82K% | -2.92K% | n/a | n/a | -306.63% | -3.62K% |
Pretax Profit Margin | -2.51K% | -2.92K% | n/a | n/a | -1.95K% | -3.61K% |
Operating Profit Margin | -2.35K% | -5.19K% | n/a | n/a | -1.9K% | -3.58K% |
FCF Margin | -1.15K% | -3.48K% | n/a | n/a | -1.21K% | -3.5K% |
EBITDA Margin | -2.28K% | -4.91K% | n/a | n/a | -1.92K% | -3.45K% |
Add to Watchlist
Select watchlists to add or remove RANI